Long-term results of a phase III clinical trial indicate survival rates for patients receiving chemoradiation for unresectable, locally advanced non-small cell lung cancer (NSCLC) may be more than twice as high as previous estimates. At five years following treatment with a standard dose of 60 Gray (Gy) radiation delivered in 30 fractions, the overall survival rate was 32 percent, setting a new benchmark of survival for patients with inoperable stage III NSCLC. The trial, RTOG 0617, also confirms that a standard dose of radiation therapy is preferable to a higher dose and that cetuximab offers no additional survival benefit for these patients. Findings were presented at the 59th Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 24-27 in San Diego.

Fujifilm Medical Systems U.S.A. Inc. recently closed new contracts to enhance diagnostic imaging capabilities for existing customers across the United States. Three healthcare systems will implement Fujifilm’s imaging solutions including mobile digital radiography (DR) systems (FDR Go), the newest DR detector (FDR D-EVO II), DR rooms (FDR Clinica Series of Components) and Fujifilm’s newest mammography solution, the Aspire Cristalle with Digital Breast Tomosynthesis (DBT).

September 21, 2017 — Medical Equipment Dynamics, provider of new, used and refurbished medical equipment, will now offer the complete RamSoft image management product suite. MED supplies a range of equipment at low costs to fit the specific needs of healthcare organizations, using a process associated with liquidating idle, decommissioned medical equipment. This eliminates unnecessary expenditures and provides a new revenue stream for healthcare facilities.